Related Experiment Video

Updated: Aug 9, 2026

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
08:42

Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures

Published on: May 26, 2023

Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells

Ho-Young Lee1, Young-Ah Suh, Jerome W Kosmeder

  • 1Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. hlee@mdanderson.org

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|February 12, 2004
PubMed

Insights

Deguelin, a natural compound, inhibits cyclooxygenase-2 (COX-2) expression and proliferation in lung cancer cells. This suggests deguelin

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Increased cyclooxygenase-2 (COX-2) expression promotes cancer and inflammation.
  • COX-2 regulation is a potential target for cancer chemoprevention.
  • Deguelin previously shown to inhibit human bronchial epithelial (HBE) cell proliferation via Akt signaling, which influences COX-2.

Purpose of the Study:

  • To investigate the effect of deguelin on COX-2 expression in squamous HBE cells.
  • To explore deguelin's impact on proliferation and apoptosis in non-small cell lung carcinoma (NSCLC) cells.

Main Methods:

  • Treatment of squamous HBE cells and NSCLC cell lines with deguelin.
  • Analysis of COX-1 and COX-2 protein levels.
  • Assessment of apoptosis-related proteins (Bax, Bcl-2) and cell cycle regulators (p53, p21, p27).

Main Results:

  • Deguelin significantly inhibited COX-2 expression in squamous HBE cells without affecting COX-1.
  • Deguelin suppressed proliferation of various NSCLC cell lines through apoptosis induction.
  • Deguelin increased Bax, p53, p21, and p27 expression while not altering Bcl-2 levels.

Conclusions:

  • Deguelin effectively inhibits COX-2 expression in lung cancer cells.
  • The chemopreventive effects of deguelin in lung cancer are linked to the regulation of COX-2 expression.
  • Deguelin's induction of apoptosis and cell cycle inhibition contributes to its anti-cancer activity.

More Related Videos

In Vitro Model for Studying Differentiation and Changes of Multi-Omics on Murine Airway Epithelial Cells Stimulated with Cigarette Smoke Extract09:07

In Vitro Model for Studying Differentiation and Changes of Multi-Omics on Murine Airway Epithelial Cells Stimulated with Cigarette Smoke Extract

Published on: July 12, 2024

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.